Evaluating the seroprevalence of SARS-CoV-2 IgG in five different districts of Bangladesh. A seroepidemiological study

Evaluating the seroprevalence of SARS-CoV-2 IgG in five different districts of Bangladesh. A seroepidemiological study

Background: We aimed to measure the seroprevalences and levels of anti-SARS-CoV-2 IgG in children, unvaccinated and vaccinated adults in five districts of Bangladesh and thus, investigate the association of seroprevalence and anti-SARS-CoV-2 IgG level with respect to different attributes of study pa...

Full description

Bibliographic Details
Main Authors:	Abdullah Al Saba, Mohammad Sayem, Razoan Al Rimon, Mousumi Sanyal, Sajib Chakraborty, Md Arifur Rahman, Md Mizanur Rahman, A.H.M. Nurun Nabi
Format:	Article
Language:	English
Published:	Elsevier 2023-06-01
Series:	Journal of Infection and Public Health
Subjects:	COVID-19 SARS-CoV-2 Seroprevalence Anti-SARS-CoV-2 IgG Seroepidemiology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1876034123001338

Similar Items

SARS-CoV-2 seroprevalence study in Lambayeque, Peru. June–July 2020
by: Cristian Díaz-Vélez, et al.
Published: (2021-04-01)

COVID-19 in Tunisia (North Africa): Seroprevalence of SARS-CoV-2 in the General Population of the Capital City Tunis
by: Ines Cherif, et al.
Published: (2022-04-01)

The Seroprevalence and Seropositivity of SARS-CoV-2 among Healthcare Workers during the Third Pandemic Wave
by: Atefeh Vaezi, et al.
Published: (2022-12-01)

The SARS-CoV-2 Infection Among Students in the University of Porto: A Cross-Sectional Study
by: Paula Meireles, et al.
Published: (2022-10-01)

Longitudinal Rise in Seroprevalence of SARS-CoV-2 Infections in Children in Western Germany—A Blind Spot in Epidemiology?
by: Folke Brinkmann, et al.
Published: (2021-11-01)

Pediatric SARS-CoV-2 seroprevalence during mitigation procedures in Southwestern Pennsylvania
by: Glenn J. Rapsinski, MD, PhD, et al.
Published: (2021-09-01)

Community SARS-CoV-2 seroprevalence before and after the second wave of SARS-CoV-2 infection in Harare, Zimbabwe
by: Arun Fryatt, et al.
Published: (2021-11-01)

SARS-CoV-2 Circulation during the First Year of the Pandemic: A Seroprevalence Study from January to December 2020 in Tuscany, Italy
by: Serena Marchi, et al.
Published: (2022-06-01)

Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil
by: Beatriz Helena Tess, et al.
Published: (2021-07-01)

Seroprevalence of IgA and IgG against SARS-CoV-2 and Risk Factors in Workers from Public Markets of Guatemala
by: Laura M. Grajeda, et al.
Published: (2023-09-01)

Differences in SARS-COV-2 seroprevalence in the population of Cusco, Peru
by: Charles Huamaní, et al.
Published: (2024-06-01)

Seroprevalence of Antibodies against SARS-CoV-2 among the Personnel and Students of the National and Kapodistrian University of Athens, Greece: A Preliminary Report
by: Ourania E. Tsitsilonis, et al.
Published: (2020-09-01)

Nationwide retrospective mortality and seroprevalence of SARS-CoV-2 antibodies in Cameroon
by: J. Eyong, et al.
Published: (2023-11-01)

SARS-CoV-2 Seroprevalence in Children under 5 Years Old—A Regional Seroepidemiological Study
by: Felicia Trofin, et al.
Published: (2024-02-01)

Risk factors and titers of COVID-19 infection in a longitudinal statewide seroepidemiology cohort
by: Elizabeth T. Rogawski McQuade, et al.
Published: (2023-10-01)

SARS-CoV-2 Seroprevalence in Lithuania: Results of National Population Survey
by: Kastytis Šmigelskas, et al.
Published: (2021-01-01)

A framework for seroepidemiologic investigations in future pandemics: insights from an evaluation of WHO’s Unity Studies initiative
by: Karen Hennessey, et al.
Published: (2023-05-01)

Community seroprevalence and risk factors for SARS-CoV-2 infection in different subpopulations in Vellore, India, and their implications for future prevention
by: Divya Dayanand, et al.
Published: (2022-03-01)

Riding high: seroprevalence of SARS-CoV-2 after 4 pandemic waves in Manitoba, Canada, April 2020–February 2022
by: Scotty Duong, et al.
Published: (2023-12-01)

Seroprevalence of SARS-CoV-2: Insights into the epidemiology of the pandemic
by: Amjad Ali, et al.
Published: (2023-08-01)

SARS-CoV-2 seroprevalence and infection rate in Manila, Philippines prior to national vaccination program implementation: a repeated cross-sectional analysis
by: Greco Mark B. Malijan, et al.
Published: (2022-10-01)

Seroprevalence of anti SARS-CoV2 antibodies in Umbrian persons living with HIV
by: chiara papalini, et al.
Published: (2020-10-01)

Prevalence of SARS-CoV-2 infection in Italian pediatric population: a regional seroepidemiological study
by: Manola Comar, et al.
Published: (2021-06-01)

Seroprevalence of SARS-CoV-2 Infection Among People Living with HIV in Libreville, Gabon
by: Samira Zoa-Assoumou, et al.
Published: (2024-12-01)

High SARS-CoV-2 seroprevalence among street adolescents in Lomé, Togo, 2021
by: Arnold Junior Sadio, et al.
Published: (2023-04-01)

SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey
by: Abbas Hoballah, et al.
Published: (2022-01-01)

A community based seroprevalence of SARS‐CoV‐2 antibodies in Somali Region, Eastern Ethiopia
by: Solomon Yared, et al.
Published: (2024-01-01)

High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Children in Vietnam: An Observational, Hospital-Based Study
by: Dien Minh Tran, et al.
Published: (2022-11-01)

Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era
by: Cassandra N. Reedman, et al.
Published: (2022-04-01)

Isolation of SARS-CoV-2 from the air in a car driven by a COVID patient with mild illness
by: John A. Lednicky, et al.
Published: (2021-07-01)

Seroprevalence and infection fatality rate of the SARS-CoV-2 Omicron variant in Denmark: A nationwide serosurveillance study
by: Christian Erikstrup, et al.
Published: (2022-10-01)

SARS-CoV-2 seroprevalence among people living with HIV in the German HIV-1 Seroconverter Cohort, 2020–2022
by: Oliver Hohn, et al.
Published: (2024-11-01)

SARS-CoV-2 antibody seroprevalence in Togo: a national cross-sectional household survey, May–June, 2021
by: Yao Rodion Konu, et al.
Published: (2022-12-01)

SARS-CoV-2 seroprevalence rates of children seeking medical care in Louisiana during the state stay at home order
by: Monika L. Dietrich, et al.
Published: (2021-12-01)

SARS‐CoV‐2 seroprevalence and associated factors among people living with HIV in Sierra Leone
by: Wei Sun, et al.
Published: (2024-07-01)

SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021
by: Jonathan Mandolo, et al.
Published: (2021-11-01)

Exploring the long-term seroprevalence of SARS-CoV-2 antibodies in infants born to women with clinical or laboratory-confirmed COVID-19
by: Uswa Jiwani, et al.
Published: (2024-05-01)

Changes in the seroprevalence and risk factors between the first and second waves of COVID-19 in a metropolis in the Brazilian Amazon
by: Maria Karoliny da Silva Torres, et al.
Published: (2022-09-01)

Trends in SARS-CoV-2 seroprevalence in Albania during the 2021–2022 pandemic year
by: Genc Sulcebe, et al.
Published: (2024-01-01)

A Cross-Sectional Study of SARS-CoV-2 Seroprevalence between Fall 2020 and February 2021 in Allegheny County, Western Pennsylvania, USA
by: Lingqing Xu, et al.
Published: (2021-06-01)